Bao-Hua Jiao
Overview
Explore the profile of Bao-Hua Jiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Jiao B, Wu J, Yang J, Hu Y, Cui K
CNS Neurosci Ther
. 2022 Oct;
28(12):2319-2330.
PMID: 36184801
Aims: We aimed to investigate the role of receptor-interacting protein 2 (RIP2) in regulation of stemness of glioma cells and chemotherapy resistance. Methods: Plasmid transfection was used to overexpress RIP2....
2.
Hu Y, Jiao B, Wang C, Wu J
CNS Neurosci Ther
. 2021 Jan;
27(5):552-563.
PMID: 33460245
Background: Temozolomide (TMZ) is a first-line chemotherapy drug for the treatment of malignant glioma and resistance to it poses a major challenge. Receptor-interacting protein 2 (RIP2) is associated with the...
3.
Sun W, Kang T, Wang Y, Sun J, Li C, Liu H, et al.
Biosci Rep
. 2018 Dec;
39(1).
PMID: 30498093
The present study was undertaken to investigate the underlying mechanisms of long noncoding RNA OIP5-AS1 via regulating miR-410 to modulate Wnt-7b in the progression of glioma. To address this problem,...
4.
Yang J, Liu H, Wang Y, Li C, Yang J, Yang L, et al.
CNS Neurol Disord Drug Targets
. 2018 Nov;
18(1):78-87.
PMID: 30394221
Background And Objective: Exosomes communicate inter-cellularly and miRNAs play critical roles in this scenario. MiR-214-5p was implicated in multiple tumors with diverse functions uncovered. However, whether miR-214-5p is mechanistically involved...
5.
Tong J, Li J, Zhang Q, Yang J, Zhang L, Liu H, et al.
Oncol Lett
. 2018 Jul;
16(2):2525-2532.
PMID: 30013647
Radiation therapy is important for the comprehensive treatment of intracranial tumors. However, the molecular mechanisms underlying the pathogenesis of delayed cognitive dysfunction are not well-defined and effective treatments or prevention...
6.
Yang J, Song J, Huo H, Zhao Y, Zhang G, Zhao Z, et al.
Ther Adv Med Oncol
. 2018 Feb;
9(12):741-754.
PMID: 29449895
Background: Glioblastoma multiforme (GBM) is the most aggressive and deadly primary brain cancer that arises from astrocytes and classified as grade IV. Recently, exosomes have been reported as an essential...
7.
Yang J, Yang J, Li C, Cui Z, Liu H, Sun X, et al.
Biochem Biophys Res Commun
. 2017 Oct;
494(3-4):674-680.
PMID: 29066350
ZMYND11 (zinc finger MYND-type containing 11) has been widely regarded to be involved in a variety of cancers as a potential suppressor. However, the biological role and mechanism of ZMYND11...
8.
Wang S, Feng L, Hu B, Lu Y, Wang W, Guo W, et al.
Mol Ther Nucleic Acids
. 2017 Sep;
8:482-492.
PMID: 28918048
Recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), as a novel cancer therapeutic, is being tested in phase II and III clinical trials; however, TRAIL resistance remains a big obstacle...
9.
Yang J, Yang J, Tong J, Jing S, Fan B, Wang F, et al.
J Neurooncol
. 2016 Nov;
131(2):255-265.
PMID: 27837435
MicroRNA is an important regulator of glioblastoma. This study aims at validating microRNA-221 (miR-221) as a biomarker for glioblastoma, and understanding how miR-221 regulates glioblastoma progression. Using clinical samples, miR-221...
10.
Fan B, Jiao B, Fan F, Lu S, Song J, Guo C, et al.
Int J Oncol
. 2015 Jul;
47(3):1025-33.
PMID: 26165303
Gliomas are the most common and aggressive types of tumors in human brain, of which the prognosis remains dismal because of their biological behavior. The involvement of miRNAs in tumorigenesis...